Syneos Health Inc (SYNH) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Syneos Health Inc   (NASDAQ: SYNH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Syneos Health Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SYNH Gross Profit Margin (Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3 		(Jun 30 2022)
Q2
Y / Y Revenue Change 0.39 %
Seq. Revenue Change 0.68 %
Revenue In Millions $1,366.08
Gross Profit Margin 21.57 %
Gross Profit Margin Total Ranking # 3207
Gross Profit In Millions $294.72
Y / Y Gross Profit Change -9.55 %
Seq. Gross Profit Change 9.87 %


Commenting Second Quarter 2023 Gross Profit Margin
Syneos Health Inc Gross Profit grew by 9.87 % in Q2 sequentially to 295 millions, while Revenue increased by 0.68 %, this led to improvement in the company's Gross Profit Margin to 21.57 %, Gross Profit Margin remained below Syneos Health Inc average.


Observing second quarter 2023 results within Medical Laboratories industry 27 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 3207, from total ranking in the previous quarter at 3298.
Learn about Gross Margin
SYNH's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 28
Healthcare Sector # 467
Overall # 3158

Gross Profit Margin Statistics
High Average Low
64.4 % 38.41 % 19.77 %
(Dec 31 2015)   (Mar 31 2023)


SYNH Gross Income Trends • More of SYNH's Profitabilty Ratios • SYNH Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
SYNH's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SYNH's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SYNH's Competitors
Gross Profit Margin Profit Margin for Syneos Health Inc 's Suppliers
Gross Profit Margin Profit Margin for SYNH's Customers

You may also want to know
SYNH's Annual Growth Rates SYNH's Profitability Ratios SYNH's Asset Turnover Ratio SYNH's Dividend Growth
SYNH's Roe SYNH's Valuation Ratios SYNH's Financial Strength Ratios SYNH's Gross Profit Growth
SYNH's Roa SYNH's Inventory Turnover Ratio SYNH's Growth Rates SYNH's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Medical Laboratories Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue
Exagen Inc   58.72 %$ 8.301  Millions$ 14.137  Millions
Luna Innovations Inc  58.43 %$ 16.865  Millions$ 28.865  Millions
Somalogic Inc   52.72 %$ 10.791  Millions$ 20.468  Millions
Ge Healthcare Technologies Inc   48.21 %$ 1,940.000  Millions$ 4,024.000  Millions
Ispecimen inc   47.47 %$ 0.772  Millions$ 1.625  Millions
American Shared Hospital Services  45.63 %$ 2.518  Millions$ 5.518  Millions
Charles River Laboratories International inc   45.46 %$ 481.838  Millions$ 1,059.937  Millions
Natera Inc   45.37 %$ 118.596  Millions$ 261.404  Millions
Psychemedics Corporation  40.70 %$ 2.059  Millions$ 5.059  Millions
Hologic Inc  37.33 %$ 367.500  Millions$ 984.400  Millions
Iqvia Holdings Inc   34.47 %$ 1,285.000  Millions$ 3,728.000  Millions
Quest Diagnostics Inc  33.88 %$ 792.000  Millions$ 2,338.000  Millions
Fulgent Genetics Inc   30.44 %$ 20.572  Millions$ 67.572  Millions
Personalis Inc   28.70 %$ 4.792  Millions$ 16.699  Millions
Labcorp Holdings Inc   27.76 %$ 842.200  Millions$ 3,033.700  Millions
Invitae Corporation  27.43 %$ 33.058  Millions$ 120.532  Millions
Medpace Holdings Inc   26.97 %$ 124.317  Millions$ 460.868  Millions
Syneos Health Inc   21.57 %$ 294.717  Millions$ 1,366.080  Millions
Renalytix Plc  21.16 %$ 0.720  Millions$ 3.403  Millions
Fortrea Holdings Inc   18.11 %$ 143.600  Millions$ 793.000  Millions
Akumin Inc   14.25 %$ 26.345  Millions$ 184.840  Millions
Bionexus Gene Lab Corp   13.23 %$ 0.340  Millions$ 2.567  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.